![](/img/cover-not-exists.png)
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib
Hantschel, O., Rix, U., Schmidt, U., Burckstummer, T., Kneidinger, M., Schutze, G., Colinge, J., Bennett, K. L., Ellmeier, W., Valent, P., Superti-Furga, G.Volume:
104
Language:
english
Journal:
Proceedings of the National Academy of Sciences
DOI:
10.1073/pnas.0702654104
Date:
August, 2007
File:
PDF, 1.08 MB
english, 2007